Clinical Trial Update: Effect of Perioperative Tranexamic Acid on Blood Loss During Management of Maxillofacial Trauma [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating perioperative tranexamic acid to reduce blood loss during maxillofacial trauma management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss As Condition Related to Surgery
• Maxillofacial Trauma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: College of Medical Sciences Teaching Hospital. Nepal | Conditions: Blood Loss | Phase 4 | Status: UNKNOWN